256 related articles for article (PubMed ID: 33322851)
1. Role of Akt1 in renal fibrosis and tubular dedifferentiation during the progression of acute kidney injury to chronic kidney disease.
Kim IY; Park YK; Song SH; Seong EY; Lee DW; Bae SS; Lee SB
Korean J Intern Med; 2021 Jul; 36(4):962-974. PubMed ID: 33322851
[TBL] [Abstract][Full Text] [Related]
2. Akt1 is involved in renal fibrosis and tubular apoptosis in a murine model of acute kidney injury-to-chronic kidney disease transition.
Kim IY; Song SH; Seong EY; Lee DW; Bae SS; Lee SB
Exp Cell Res; 2023 Mar; 424(2):113509. PubMed ID: 36773738
[TBL] [Abstract][Full Text] [Related]
3. Akt1 is involved in tubular apoptosis and inflammatory response during renal ischemia-reperfusion injury.
Kim IY; Park YK; Song SH; Seong EY; Lee DW; Bae SS; Lee SB
Mol Biol Rep; 2020 Dec; 47(12):9511-9520. PubMed ID: 33247386
[TBL] [Abstract][Full Text] [Related]
4. Indoleamine-2,3-Dioxygenase Activates Wnt/β-Catenin Inducing Kidney Fibrosis after Acute Kidney Injury.
Pan B; Zhang H; Hong Y; Ma M; Wan X; Cao C
Gerontology; 2021; 67(5):611-619. PubMed ID: 34130288
[TBL] [Abstract][Full Text] [Related]
5. Effects of contralateral nephrectomy timing and ischemic conditions on kidney fibrosis after unilateral kidney ischemia-reperfusion injury.
Zhang J; Shen R; Lin H; Pan J; Feng X; Lin L; Niu D; Hou Y; Su X; Wang C; Wang L; Qiao X
Ren Fail; 2022 Dec; 44(1):1568-1584. PubMed ID: 36154902
[TBL] [Abstract][Full Text] [Related]
6. A network pharmacology-based study on the mechanism of astragaloside IV alleviating renal fibrosis through the AKT1/GSK-3β pathway.
Yu X; Xiao Q; Yu X; Cheng Y; Lin H; Xiang Z
J Ethnopharmacol; 2022 Oct; 297():115535. PubMed ID: 35840059
[TBL] [Abstract][Full Text] [Related]
7. cMet agonistic antibody prevents acute kidney injury to chronic kidney disease transition by suppressing Smurf1 and activating Smad7.
Li L; Lee J; Cho A; Kim JH; Ju W; An JN; Park JH; Zhu SM; Lee J; Yu SS; Lim CS; Kim DK; Kim YS; Yang SH; Lee JP
Clin Sci (Lond); 2021 Jun; 135(11):1427-1444. PubMed ID: 34061176
[TBL] [Abstract][Full Text] [Related]
8. Early elimination of uremic toxin ameliorates AKI-to-CKD transition.
Chen JH; Chao CT; Huang JW; Hung KY; Liu SH; Tarng DC; Chiang CK
Clin Sci (Lond); 2021 Dec; 135(23):2643-2658. PubMed ID: 34796904
[TBL] [Abstract][Full Text] [Related]
9. Knockout of Zeb2 ameliorates progression of renal tubulointerstitial fibrosis in a mouse model of renal ischemia-reperfusion injury.
Inotani S; Taniguchi Y; Nakamura K; Nishikawa H; Matsumoto T; Horino T; Fujimoto S; Sano S; Yanagita M; Terada Y
Nephrol Dial Transplant; 2022 Feb; 37(3):454-468. PubMed ID: 34724064
[TBL] [Abstract][Full Text] [Related]
10. The PAR-1 antagonist vorapaxar ameliorates kidney injury and tubulointerstitial fibrosis.
Lok SWY; Yiu WH; Li H; Xue R; Zou Y; Li B; Chan KW; Chan LYY; Leung JCK; Lai KN; Tang SCW
Clin Sci (Lond); 2020 Nov; 134(21):2873-2891. PubMed ID: 33078834
[TBL] [Abstract][Full Text] [Related]
11. The down-regulation of XBP1, an unfolded protein response effector, promotes acute kidney injury to chronic kidney disease transition.
Chen JH; Wu CH; Jheng JR; Chao CT; Huang JW; Hung KY; Liu SH; Chiang CK
J Biomed Sci; 2022 Jun; 29(1):46. PubMed ID: 35765067
[TBL] [Abstract][Full Text] [Related]
12. Deletion of
Kim IY; Lee MY; Park MW; Seong EY; Lee DW; Lee SB; Bae SS; Kim SS; Song SH
Biomed Res Int; 2020; 2020():6143542. PubMed ID: 33299873
[TBL] [Abstract][Full Text] [Related]
13. Gremlin1 and TGF-β1 protect kidney tubular epithelial cells from ischemia-reperfusion injury through different pathways.
Gao X; Han L; Yao X; Ma L
Int Urol Nephrol; 2022 Jun; 54(6):1311-1321. PubMed ID: 34633599
[TBL] [Abstract][Full Text] [Related]
14. Tubular cell-derived exosomal miR-150-5p contributes to renal fibrosis following unilateral ischemia-reperfusion injury by activating fibroblast
Zhou X; Zhao S; Li W; Ruan Y; Yuan R; Ning J; Jiang K; Xie J; Yao X; Li H; Li C; Rao T; Yu W; Cheng F
Int J Biol Sci; 2021; 17(14):4021-4033. PubMed ID: 34671216
[TBL] [Abstract][Full Text] [Related]
15. [Effect of a novel phosphodiesterase 5 inhibitor, CPD1, on renal interstitial fibrosis after unilateral renal ischemia-reperfusion injury].
Liu AL; Li Z; Lu MZ; Qiu HH; Xie ZL; Liu XQ; Zhao AZ; Mu YP; Li FH
Sheng Li Xue Bao; 2023 Feb; 75(1):1-9. PubMed ID: 36859829
[TBL] [Abstract][Full Text] [Related]
16. Divergent effects of AKI to CKD models on inflammation and fibrosis.
Black LM; Lever JM; Traylor AM; Chen B; Yang Z; Esman SK; Jiang Y; Cutter GR; Boddu R; George JF; Agarwal A
Am J Physiol Renal Physiol; 2018 Oct; 315(4):F1107-F1118. PubMed ID: 29897282
[TBL] [Abstract][Full Text] [Related]
17. ErbB4 deletion accelerates renal fibrosis following renal injury.
Zeng F; Miyazawa T; Kloepfer LA; Harris RC
Am J Physiol Renal Physiol; 2018 May; 314(5):F773-F787. PubMed ID: 28724608
[TBL] [Abstract][Full Text] [Related]
18. NFAT inhibitor 11R-VIVIT ameliorates mouse renal fibrosis after ischemia-reperfusion-induced acute kidney injury.
Xie ZY; Dong W; Zhang L; Wang MJ; Xiao ZM; Zhang YH; Shi WX; Huang Y; Yang Y; Li CL; Fu L; Zhao XC; Li RZ; Li ZL; Chen YH; Ye ZM; Liu SX; Dong Z; Liang XL
Acta Pharmacol Sin; 2022 Aug; 43(8):2081-2093. PubMed ID: 34937917
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus-mediated P311 ameliorates renal fibrosis through inhibition of epithelial-mesenchymal transition via TGF-β1-Smad-ILK pathway in unilateral ureteral obstruction rats.
Qi FH; Cai PP; Liu X; Si GM
Int J Mol Med; 2018 May; 41(5):3015-3023. PubMed ID: 29436600
[TBL] [Abstract][Full Text] [Related]
20. Diabetes Aggravates Post-ischaemic Renal Fibrosis through Persistent Activation of TGF-β
Kim DJ; Kang JM; Park SH; Kwon HK; Song SJ; Moon H; Kim SM; Seo JW; Lee YH; Kim YG; Moon JY; Lee SY; Son Y; Lee SH
Sci Rep; 2017 Dec; 7(1):16782. PubMed ID: 29196746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
